Prevention of preeclampsia with aspirin
Preeclampsia is defined as hypertension arising after 20 weeks of gestational age with
proteinuria or other signs of end-organ damage and is an important cause of maternal and …
proteinuria or other signs of end-organ damage and is an important cause of maternal and …
[HTML][HTML] Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies
Objective To develop a practical evidence based list of clinical risk factors that can be
assessed by a clinician at≤ 16 weeks' gestation to estimate a woman's risk of pre …
assessed by a clinician at≤ 16 weeks' gestation to estimate a woman's risk of pre …
[HTML][HTML] Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors
T Tomimatsu, K Mimura, S Matsuzaki, M Endo… - International journal of …, 2019 - mdpi.com
Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and
proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal …
proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal …
Prevention of preeclampsia
M Ma'ayeh, MM Costantine - Seminars in Fetal and Neonatal Medicine, 2020 - Elsevier
Preeclampsia is an obstetric disorder that affects 3–8% of pregnant women and remains a
leading cause of short-and long-term neonatal and maternal morbidity and mortality …
leading cause of short-and long-term neonatal and maternal morbidity and mortality …
Aspirin for prevention of preeclampsia
A Atallah, E Lecarpentier, F Goffinet, M Doret-Dion… - Drugs, 2017 - Springer
Aspirin is currently the most widely prescribed treatment in the prevention of cardiovascular
complications. The indications for the use of aspirin during pregnancy are, however, the …
complications. The indications for the use of aspirin during pregnancy are, however, the …
Adaptations of the human placenta to hypoxia: opportunities for interventions in fetal growth restriction
BACKGROUND The placenta is the functional interface between the mother and the fetus
during pregnancy, and a critical determinant of fetal growth and life-long health. In the first …
during pregnancy, and a critical determinant of fetal growth and life-long health. In the first …
[HTML][HTML] An overview of obesity, cholesterol, and systemic inflammation in preeclampsia
Preeclampsia (PE), an inflammatory state during pregnancy, is a significant cause of
maternal and fetal morbidity and mortality. Adverse outcomes associated with PE include …
maternal and fetal morbidity and mortality. Adverse outcomes associated with PE include …
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study
MY Kim, JP Buyon, MM Guerra, S Rana… - American journal of …, 2016 - Elsevier
Background Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE)
and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) …
and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) …
Aspirin for prevention of preeclampsia and fetal growth restriction
L Loussert, F Vidal, O Parant, SM Hamdi… - Prenatal …, 2020 - Wiley Online Library
For the past decades, growing attention has been given to aspirin use during pregnancy. It
favors placentation by its proangiogenic, antithrombotic, and anti‐inflammatory effects …
favors placentation by its proangiogenic, antithrombotic, and anti‐inflammatory effects …